Introduction {#sec1}
============

The American Academy of Orthopaedic Surgeons projects that by 2030, 30 million joint-related procedures will be performed in the United States \[[@bib1]\]. As the number of joint replacement procedures in the United States continues to rise, so does the human and economic burden of associated complications such as prosthetic joint infection (PJI). PJI is a devastating complication of total knee arthroplasty (TKA). The incidence of PJI after primary TKA is estimated to be between 1% and 2%, and this complication creates a significant burden for both the patient and the health-care system as a whole \[[@bib2],[@bib3]\]. Treatment of PJIs often necessitates revision surgery and is associated with substantial health-care costs. In fact, by 2020, the hospital-associated costs of PJIs are predicted to be greater than 1 billion U.S. dollars \[[@bib4]\].

Although the risk of death after elective TKA is very low, patients undergoing 2-stage revision TKA for infection have a mortality rate as high as 21% \[[@bib5]\]. Identification and optimization of modifiable risk factors is an important goal as up to half of all PJIs may be preventable through the application of evidence-based strategies \[[@bib6]\]. Careful patient selection and preoperative optimization of modifiable risk factors have become targets to minimize the risk of adverse outcomes such as PJIs \[[@bib7],[@bib8]\]. Unfortunately, best-practice screening guidelines and preoperative optimization are not part of the routine practice of all orthopaedic surgeons. However, recent changes to reimbursement in alternative payment models have resulted in an increased focus on the importance of patient selection to reduce costly complications in arthroplasty.

Despite literature implicating modifiable risk factors and evidence supporting implementation of preoperative optimization protocols targeting these modifiable risk factors before TKA, there are few studies that directly assess the degree of compliance to these protocols and their relationship to development of PJI. The aim of this study is to assess the relationship adherence to a preoperative optimization protocol at our institution and the rate of PJI after primary and revision TKAs.

Material and methods {#sec2}
====================

A single-institution, institutional review board (IRB)--approved, and multisurgeon retrospective study was conducted on consecutive elective primary and revision TKA procedures performed at our institution from December 1, 2015, to December 1, 2017.

A total of 683 cases were identified by querying the billing records using Current Procedural Terminology codes 27447 and 27487. Fourteen cases were excluded for the following reasons: malignancy (8), trauma (ie, periprosthetic fractures) (2), lack of follow-up (1), conversion of a patellofemoral joint replacement to a TKA (1), and surgery outside of study inclusion dates (2). All revision TKA surgeries included were aseptic revisions.

Medical records were reviewed to assess the surgical outcome and compliance with preoperative optimization including the following parameters: body mass index (BMI) ≤40 kg/m^2^, hemoglobin A1c ≤ 7.5%, hemoglobin ≥12 g/dL, albumin ≥3.5 g/dL, absence of tobacco use within 30 days before surgery, and completion of a decolonization protocol if a nasal polymerase chain reaction screening was positive for methicillin-sensitive *Staphylococcus aureus* or methicillin-resistant *Staphylococcus aureus*. Compliance with these criteria was encouraged but not mandatory for surgeons at our institution during the study period, and compliance was assessed retrospectively. IRB approval was obtained for the study.

Data collection and analysis {#sec2.1}
----------------------------

A consecutive list of all TKAs performed by all surgeons at our institution between 12/1/2015 and 12/1/2017 was obtained from the billing department as described previously. Medical records were reviewed for all patients to confirm subject eligibility, to obtain baseline characteristics, to record medical comorbidities, to assess adherence to preoperative criteria (as described previously), and to review the postoperative course to identify any infectious complications. The diagnosis of PJI was assessed for a minimum of 2 years using 2011 Musculoskeletal Infection Society criteria. All cases that had been treated as PJI but that did not strictly meet the Musculoskeletal Infection Society criteria were adjudicated by the senior authors for clarification for inclusion.

Statistical analysis {#sec2.2}
--------------------

Generalized linear mixed-effects models with a logistic link were used to test the association between preoperative optimization criteria and PJI. Models included random effects that accounted for the nesting of patient within the surgeon. The model included surgeon compliance and the surgery type (primary vs revision TKA). To account for missing data, multiple imputation via predictive mean matching with 10 imputed data sets was generated for the analysis. Individual variables were imputed (eg, smoking status, BMI), and then surgical criteria were applied. To examine the impact of individual variables on risk of infection, unadjusted, accounting for only the procedure type, and adjusted (accounting for all variables) odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were estimated using the individual variables included in the preoperative criteria. These models again accounted for nesting of the surgeon within the site. All analyses were completed using R statistical software (R Foundation for Statistical Computing Vienna, Austria). An alpha of 0.05 was used for statistical significance.

Results {#sec3}
=======

A total 669 primary and revision TKAs met inclusion criteria, including 510 primary and 159 revision TKAs. Patient age ranged from 18 to 95 years; most patients were aged between 18 and 65 years (61.3%) (see [Table 1](#tbl1){ref-type="table"}). The majority of the sample was female (60%). The patients on average were obese (mean BMI: 32.2). There was a statistically significant difference in age and BMI between the patients who met all preoperative optimization criteria and those who did not. The nonadherent patient cohort was on average younger (76% were between 18 and 65) and had a slightly higher BMI (33.2 in the nonadherent cohort vs 31.1 in the adherent cohort).Table 1Demographic characteristics.VariableTotal (%)Adherent (%)Nonadherent (%)*P* valueN (%)669410 (61.3)259 (39.7)Age, y (%)\<.001 18-65410 (61.3)173 (52.0)154 (75.9) 66-85253 (37.8)156 (46.8)48 (23.6) 86-956 (0.9)4 (1.2)1 (0.5)Gender = male265 (39.6)140 (42.0)81 (39.9).691BMI, mean (SD)32.22 (5.83)31.11 (5.01)33.21 (6.70)\<.001Revision TKA159 (23.8)65 (19.5)56 (27.6).039

The compliance rate for primary TKA was 58.2% (297/510) and 43.4% (69/159) for revision TKA. Frequency of noncompliant preoperative variables in primary and revision TKAs is outlined in [Table 2](#tbl2){ref-type="table"}. There were a total of 85 cases with missing variables, including 13 for tobacco use status, 71 for albumin level, 31 for hemoglobin A1c, and 5 for hemoglobin level.Table 2Frequency of preoperative noncompliance in primary and revision TKA cases.VariableReasons for noncompliancePrimaryRevisionBMI ≤40 kg/m^2^3221Tobacco within 30 days7127Albumin ≥3.5 g/dL5432Hemoglobin A1c ≤ 7.5%3314Hemoglobin ≥12 g/dL7242MRSA colonization137

There were 26 infections in total (3.9%). The PJI rate was 1.2% (6) among primary and 14.4% (20) among revision TKAs. The rate of PJI among cases that met the preoperative optimization criteria was 2.4% (5), and the rate among cases that did not was 6.2% (21) (*P* \< .05). Results from the generalized linear mixed-effects models demonstrated a statistically significant (*P* = .035) decrease in the PJI rate (OR: 0.34, 95% CI: 0.14, 0.83) among patients who satisfied the preoperative optimization criteria compared with those who did not. When the procedure type was included in this modeling, there was a large effect size (OR: 0.48, CI: 0.19, 1.18); however, this did not reach statistical significance (*P* = .11) ([Table 3](#tbl3){ref-type="table"}).Table 3Statistical models examining adherence to preoperative screening vs nonadherence and primary vs revision TKA.Model*P* valueOR (95% CI)Model 1[a](#tbl3fna){ref-type="table-fn"}:.01820.34 (0.14, 0.83)Model 2[b](#tbl3fnb){ref-type="table-fn"}:.11030.48 (0.19, 1.18)[^1][^2]

A univariate analysis was performed to determine the effect of individual optimization criteria. This analysis was significant only for an albumin level greater than or equal to 3.5 g/dL, which was associated with a statistically significant decrease in infections (*P* = .006, OR: 0.72, CI: 0.57-0.91) (see [Table 4](#tbl4){ref-type="table"}).Table 4Unadjusted and adjusted estimates and odds ratios for pre-operative selection criteria variablesVariableUnadjusted[a](#tbl4fna){ref-type="table-fn"}Adjusted[a](#tbl4fna){ref-type="table-fn"}EstimateSE*P* ValueOR95% CIEstimateSE*P* valueOR95% CIAge, y 19-65Refrefrefrefrefrefrefrefrefref 66-950.070.44.9821.010.41-2.46−0.080.48.8650.920.36-2.34Gender (male v female)0.610.42.1491.830.81-4.170.420.47.3671.520.61-3.82BMI0.010.03.8631.010.94-1.070.030.04.3511.040.96-1.11Smoking0.650.51.2041.920.70-5.230.650.55.2331.920.66-5.63Alcohol−0.030.47.9470.970.38-2.47−0.320.51.5210.720.27-1.96Diabetes−0.30.5.550.740.28-4.99−0.340.56.5480.710.24-2.14Albumin−0.330.12.0060.720.57-0.91−0.370.14.0070.690.53-0.90HbA1c−0.030.12.780.970.76-1.220.040.13.7441.040.81-1.34Hemoglobin0.110.11.3391.110.90-1.380.10.11.3771.110.88-1.38Decolonized0.371.19.7581.450.13-15.57−0.2−0.2.8870.820.05-14.08[^3]

Discussion {#sec4}
==========

PJI represents a serious complication of TKA, which is associated with high morbidity and mortality. The mortality rate for revision of TKAs for PJI is high, and recent evidence suggests that revision of TKA for PJI is associated with higher morbidity, mortality, and health-care expenditure than revision for aseptic causes \[[@bib9]\].

Multiple modifiable risk factors related to PJI after TKA have been characterized \[[@bib10],[@bib11]\]. Specifically, obesity, poor glycemic control, albumin levels, tobacco use, methicillin-resistant *Staphylococcus aureus* colonization, and preoperative anemia have gained the greatest attention \[[@bib10],[@bib12], [@bib13], [@bib14], [@bib15], [@bib16]\]. In our study, only hypoalbuminemia was found to be significant in the regression analysis. Other studies examining similar interventions, such as those of Nussenbaum et al. \[[@bib7]\] and Bullock et al. \[[@bib8]\], have reported comparable infection rates among primary TKAs. Both studies noted significant decreases in the infection rates after implementation of preoperative screening and optimization criteria. Although there have been several articles published examining the effect of preoperative optimization of patients who underwent TJA, to the best of our knowledge, no articles have been published examining preoperative optimization in revision TKA \[[@bib7],[@bib8]\]; thus, we are unable to provide any meaningful comparisons.

The data produced by this project suggest that optimization of these patients before revision TKA is no less important than in primary TKA. It is interesting that our statistical modeling did not demonstrate a significant difference in the infection rates when considering the procedure type (ie, primary vs revision TKAs). This is despite a clinically significant difference (greater than 3x infection rate) in the revision TKA cohort. Because the incidence of PJI is low, it is possible that our study is underpowered to determine statistically significant differences in the PJI incidence between the groups. Although our study was unable to demonstrate statistical significance when accounting for the procedure type as a variable, the demonstrated effect size was clinically significant, with an OR of 0.48 and 95% CI of 0.19-1.18. These results suggest that further study may demonstrate a clinically significant association with a lower risk of PJI if repeated.

This article has several limitations. Given the retrospective nature of our project, we cannot rule out alternative explanations for differences between the groups. Furthermore, as this is a single-institution study, the results may not be generalizable to other centers. In addition, it is possible that patients who had their index surgery at our institution subsequently received care at another institution for management of a complication such as a PJI as our protocol did not have IRB approval to contact patients during the study period to determine if patients had surgeries performed at other institutions during the study period. A further limitation is our designated optimization cutoffs. The existing articles on this topic each have different criteria; for example, Nussenbaum et al. used an HbA1c $\leq$ 7.0, whereas other studies have identified HbA1c \> 8.0 as being a risk factor for PJI \[[@bib7],[@bib10]\]. Nevertheless, the exact point at which to draw the line remains unclear and needs further study. The decision to include consecutive both component knee revisions and exclude isolated component revisions was based on an attempt to limit the risk of confounding, as it has been demonstrated in the literature that the incidence of infection and other complications differs among each subpopulation of patients undergoing the various forms of TKA revision \[[@bib17],[@bib18]\]. We chose to limit this risk of confounding a priori by only assessing both component knee revisions.

Conclusions {#sec5}
===========

Implementation of a standardized preoperative optimization protocol represents an important intervention to improve overall outcomes in primary and revision TKA. Results from this study suggest that following a preoperative optimization protocol and optimizing modifiable risk factors can decrease the risk of PJI after revision and primary TKAs. As a result of our study, we have implemented education on patient selection and optimization and have instituted monitoring and feedback to surgeons on compliance. Further prospective studies are needed to elucidate how best to implement preoperative optimization protocols among patients undergoing TKA and to determine which criteria are most influential in reducing the risk of complications.
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[^1]: Model 1 analyzed the infection rate as a function of adherence vs nonadherence to preoperative optimization criteria.

[^2]: Model 2 analyzed the infection rate taking into account adherence and primary vs revision TKA.

[^3]: Models account for the procedure type (primary vs revision).
